Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr. Zeldis was awarded an options package totaling 23,200,000 shares of common stock with the following terms:
- 3,480,000 options with a five (5) year term and exercise price of $0.10 per share vest immediately;
- 2,320,000 options with a five (5) year term and exercise price of $0.10 per share vest upon the delivery of a written three-year strategic plan (in which Dr. Zeldis actively assists) to the Company with respect to the Company's hydrogel platform (the "Platform"), provided that the report is delivered by February 17, 2013;
- 2,320,000 options with a five (5) year term and exercise price of $0.10 per share which vest upon the two year anniversary of the Company hiring a chief medical officer identified by Dr. Zeldis, provided that the chief medical officer is hired by November 17, 2012;
- 4,640,000 options with a five (5) year term and exercise price of $0.15 per share which vest upon the delivery of a written clinical program to the Company (in which Dr. Zeldis actively assists) with respect to the completion of U.S. Food and Drug Administration trials to approve the delivery of an active pharmaceutical ingredient (an "API") delivered through the Platform, provided such clinical program is delivered by May 17, 2013;
- 4,640,000 options with a five (5) year term and exercise price of $0.15 per share which vest upon the Company entering into a co-licensing agreement to develop a product that provides for the delivery of an API using the Platform, provided such co-licensing agreement is entered into by November 17, 2013; and
- 5,800,000 options with a five (5) year term and exercise price of $0.15 per share which vest upon (a) Dr. Zeldis's delivery of a written strategic plan to the Company with respect to the Company's HepaMate? product and, (b) HepaLife Biosystems, Inc., a wholly owned subsidiary of the Company, completing a financing resulting in gross proceeds of at least $2,500,000 provided such strategic plan is delivered and such financing occurs by May 17, 2013.
Pretty Good Incentives
ALQA~
General Description
SilverSealâ„¢
SilverSeal® Hydrogel dressings are cross-linked polymer based gels that may be made into sheets. Unlike antibiotics, silver works through a multimodal mechanism of action whereby pathogens from exudating wounds are safely eradicated. Silver technology has increasingly become a mainstay in hospitals in the past 3-5 years to thwart the incidence of hospital acquired infections.
Silver based wound dressings are becoming increasingly prevalent in wound care due to the recent increase of antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus, known as MRSA. Silver, when moist, emits ions. Silver ions (Ag+) are bioactive and in sufficient concentration readily kill bacteria in both external wounds and in living tissue. Unlike competing products, which are largely dry in nature, Alliqua’s dressing is approximately 95% water based; and hence, does not have the issues of requiring pre-wetting or absorption of transdermal water loss or wound exudate to become bioactive.
Alliqua’s SilverSeal® Hydrogel sheets can hold themselves in place; however, they are non-adherent (they do not bond to the wound, skin or hair) and thus can be removed without causing additional trauma to the wound bed. While many hydrogels are not highly absorptive, Alliqua’s hydrogels can absorb 2.5X their weight in exudate. Borderless hydrogel dressings may require secondary dressings.
ALQA~
From 10Q - Aug 12th
Recent Events
In May of 2012, the composition of our Board of Directors changed with the appointments of Dr. Jerome B. Zeldis and Mr. Kenneth Londoner and the resignations of Dr. Michael Goldberg and Mr. Nachum Stein. Dr. Zeldis, an experienced senior biopharmaceutical executive, is currently the CEO of Celgene Global Health and the Chief Medical Officer of Celgene Corporation. Mr. Londoner is the founder, Chairman, and CEO of BioSig Technologies, Inc., a privately held medical technology company formed in 2009. Mr. Londoner is also the Managing Partner of Endicott Management Partners, LLC, a private investment company focused on medical technology and consumer-related companies.
About Celgene (Trading at $77.86 - Nov. 12, 2012)
http://finance.yahoo.com/q?s=CELG&ql=1
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company's Web site at www.celgene.com
ALQA~
From the 10Q Today:
- "We believe our research and development expenses will continue to decrease in 2012 as the development of our proprietary products is at the point where we have successfully completed all product testing and have initiated sales into the marketplace. We have been committing non-cash resources to the further development of the HepaMate asset and have engaged leading experts in the field of liver transplant medicine to continue our efforts. We expect to formulate a detailed and strategic plan for this asset in the first half of 2013."
We believe that our need for additional equity capital will continue and we intend to pursue additional financing from existing relationships (such as prior shareholders, investors and lenders) and from new investors to support our research and development programs and operations. In addition, we may pursue sources of additional capital through various means, including joint ventures, debt financing, or equity financing. We intend to engage investment banking firms to assist us with these efforts.
Based on current forecasts, which include improving sales orders from our principal contract manufacturing customer, sales orders from our new line of proprietary products and our ability to manufacture and successfully fulfill these orders, we believe our cash and cash equivalents, anticipated cash flows from operations, and other external sources of credit will be sufficient to meet our cash requirements through the third quarter of 2013. It is difficult to accurately predict cash flow due to various factors, including estimating potential demand for our products as we are entering new markets and varying demand levels from our major customers."
Go Alliqua~ Go!!!
Lots of people look for the QUICK flip,
but some take TIME. People want to see GAINS NOW!!!!
Doesn't always happen like that
There is plenty of information on this board, support the
Fundamental Strenght of this company. The charts will follow.
GO ALQA
HAPPY THANKSGIVING ALL~
Nice...
They are just toying with nervous investors with their
jittery trigger fingers on the sell button.
How bad do you people want your shares?
This stock will leave
impatient people angry and upset in the end.
Once it gets moving, it will run up to about .12+
Consolidate in the .09-.10 area, then run up to high
teens, possibly .20+
When you sell and turn your head, is when they run
it right past you with YOUR shares. LMAO
Average down, or take a LOSS
GL-
ALQA, SLEEPER STOCK
LOL... at the baby dip
Don't sell. unless you really need the money
See how they move the ask right back to .07
No Panic, Just Patience....
ALQA~
MM's trying to shake....
They are nervous and manipulating,
trying to slow down buying pressure.
It will come~ People will average down
on this if are they are that STUPID!!!!!!!!!!!!
Tic Toc....
ALQA
Don't worry baby, We woke you.
Go back to sleep and keep drinking your milk.
Lol. WEEEEEEEEEEEEEEEEE!
.07 on the ask! Nice =)
Would be nice if Sapirstein went back to Gilead and tried
to allign their drugs with Alliqua's "Patented Transdermal Technology" Hmmmmm...
Yes Sir...
HOLDING ALQA - No concerns!
Looking for new HOD before close?
More recently, Mr. Sapirstein has turn good known in the attention as a start-up and turnaround specialist, especially for his work at Gilead Sciences, Inc., Serono Laboratories, Inc., and Tobira Therapeutics, Inc. Mr. Sapirstein served in the Global Marketing organisation at Gilead, commencement in 2000 where he led and grown the tellurian selling plan for the flagship HIV drug Viread. He played a key purpose in the expansion of the drug mixed plan which resulted in Gilead’s merger of Triangle’s nucleoside portfolio. That merger in conclusion led to the launch of Truvada, Gilead’s multi-billion dollar mixed HIV drug.
http://www.financialeveryday.com/alliqua-appoints-james-sapirstein-as-ceo-as-company-focuses-on-strategic-growth-plan/
Mr. Sapirstein served in the Global Marketing organization at Gilead, commencement in 2000 where he led and grown the tellurian selling plan for the flagship HIV drug Viread.
(GILD) - Gilead Sciences, Now Trading at $70.00+/share (WAS AT $3.00) when his role in Global Marketing began.
He played a key purpose in the expansion of the drug mixed plan which resulted in Gilead’s merger of Triangle’s nucleoside portfolio. That merger in conclusion led to the launch of Truvada, Gilead’s multi-billion dollar mixed HIV drug.
Amazing...
I think since he JUUUuuussst came on board with us, It's safe
to say that the company is headed in the right direction.
GO ALLIQUA~
Sapirstein + Laudano + ALQA = $$$$$$
Patience
Bags Coming~
Gobble Gobble =)
ALQA Shares
Greeeeeeen!
People see that there is not much selling
Love the Patience and Awareness I see.
Keep it up Guys~
ALQA $$$$$$
Very slow day but oh well
Whats up GTG?
Today's news was kind of a curve ball.
Everyone was expecting some type of news & development
about the conference and updates on SILVERSEAL and
the launch of the new sales initiative. I think when they get back
on that track, we run harder. This news is too speculative and forward
looking. People, well at least I know am, waiting on distribution channels,
contracts, new product, new appointment. Overall still solid as a rock, but
I think they should stay in one lane for now until we get the pop we need.
Haven't read all posts so I hope I'm not reiterating someone else's thoughts
GL~
Patience Boys...and girls?
GO ALQA
North not South!
Yes sir, patiently watching.... Tick Tock tick!
Almost time for Mondays opening bell,
I have a feeling we are going to get some JUICY
THANKSGIVING NEWS THIS WEEK!!!!!!!
Good Luck All...
ALQA READY FOR TAKEOFF
What's the most would you invest in this?
Thinking about putting in $3k more on Tuesday
Hopefully I don't have to buy in the .08's
Blockbuster FDA Approved Product and High Powered Players involved
in this company. Should see some nice Green Pastures on this ride.
ALQA ON THE RISE!!!!!
Sup D€N
With their facility ALQA says they are immediately prepared for $80 mil in sales. That would
put us at a .34 share price. That is about 600%+ gains from initial alert at .054,
which is less than half of what their last pick @MBS did. I think we can do that.
Market Cap would be about $80 mil. Company positioned to move into untapped revenue
stream of $100 mil+ with potential to use "Transdermal Technology" with Big Pharma companies.
The hiring of Mr. Laudano as VP of Medical Affairs is HUGE for us!!!!!!!
Go ALQA
KEEP CLIMBING TO NEW HEIGHTS!!!!!!
Lookin for .25+
I wouldn't be surprised to see some type of distribution in the coming weeks.
With this powerful team of execs we can get to this level and higher
The company traded a few 4 mil share days right before and after that high of .30
back in April of 2011.
Haven't been around long enough to know why the price got so low but
it feels like its about time for this company to start making some moves
Yeah morning time over here in California
6's are the loading zone IMO
I need about 50-60k more shares....
Then I'll be happy
Mornin 'Lito
Yes brother would be nice to hear some news and
See ALQA climb higher. That chart is screaming BREAKOUT!!!!
Mornin 'Lito
Yes brother would be nice to hear some news and
See ALQA climb higher. That chart is screaming BREAKOUT!!!!
Good day and week.
Should heat up a little bit more next week
ALQA CLIMBING!!!!!
Right on...
This is I think my last post I think for the day, but I'm with you.
That shouldnt be out of the question at all. Maybe in a month or so?...
I don't know... I will be adding more on Monday or Tuesday next week.
Wish I could fastforward to see what the share price is like a month from
now. I feel like we are all gonna be happy. I've held on less promising companies
longer than a month so watching this one will be interesting to see how the
CEO and SAB (Scientific Advisory Board) Launch this product. They are very well respected
Leaders so lets see what they do at Alliqua.
GO ALQA
I know but it seems that they are playing games
Or someone is trying to get out because they are impatient.
I'm not sure but I'm holding...
That's right and plus I don't think many are looking to sell to MM's down here
Lots of patient investors on board here. Lots of potential with this stock
Half of yesterday volume in the first two ours of trading
More investors noticing....
Looking good for us all....